Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 8 studies | 21% ± 5% | |
| mucosal invariant T cell | 7 studies | 22% ± 6% | |
| CD4-positive, alpha-beta T cell | 7 studies | 26% ± 8% | |
| T cell | 6 studies | 20% ± 4% | |
| effector memory CD8-positive, alpha-beta T cell | 5 studies | 24% ± 4% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 19% ± 5% | |
| glutamatergic neuron | 3 studies | 29% ± 9% | |
| lymphocyte | 3 studies | 31% ± 12% | |
| gamma-delta T cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of PBX4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2436.36 | 653 / 653 | 99% | 8.28 | 599 / 605 |
| ovary | 97% | 189.11 | 175 / 180 | 97% | 4.65 | 417 / 430 |
| lung | 100% | 283.85 | 577 / 578 | 91% | 3.67 | 1055 / 1155 |
| stomach | 83% | 136.21 | 297 / 359 | 97% | 4.89 | 277 / 286 |
| kidney | 96% | 147.96 | 85 / 89 | 79% | 2.93 | 709 / 901 |
| brain | 90% | 110.35 | 2383 / 2642 | 84% | 2.32 | 591 / 705 |
| intestine | 75% | 178.65 | 724 / 966 | 98% | 5.35 | 518 / 527 |
| prostate | 98% | 195.06 | 240 / 245 | 70% | 1.58 | 352 / 502 |
| bladder | 71% | 149.05 | 15 / 21 | 96% | 6.69 | 485 / 504 |
| skin | 99% | 187.65 | 1795 / 1809 | 68% | 2.47 | 323 / 472 |
| breast | 99% | 158.44 | 454 / 459 | 63% | 1.71 | 708 / 1118 |
| uterus | 59% | 67.55 | 101 / 170 | 97% | 5.64 | 446 / 459 |
| esophagus | 61% | 49.17 | 887 / 1445 | 91% | 4.22 | 167 / 183 |
| pancreas | 24% | 14.04 | 80 / 328 | 95% | 5.47 | 169 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.50 | 29 / 29 |
| spleen | 100% | 389.12 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.68 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 5.59 | 44 / 45 |
| adipose | 97% | 149.31 | 1171 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 271.11 | 889 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 15% | 8.14 | 39 / 258 | 60% | 1.58 | 138 / 230 |
| liver | 18% | 9.96 | 40 / 226 | 19% | 0.61 | 79 / 406 |
| blood vessel | 23% | 19.97 | 302 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 14% | 0.24 | 11 / 80 |
| heart | 9% | 5.49 | 77 / 861 | 0% | 0 | 0 / 0 |
| muscle | 2% | 1.37 | 18 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007420 | Biological process | brain development |
| GO_0048568 | Biological process | embryonic organ development |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0048666 | Biological process | neuron development |
| GO_0001654 | Biological process | eye development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0001741 | Cellular component | XY body |
| GO_0005634 | Cellular component | nucleus |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | PBX4 |
| Protein name | Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4) PBX homeobox 4 |
| Synonyms | |
| Description | |
| Accessions | Q9BYU1 ENST00000557978.6 H0YL59 ENST00000251203.14 ENST00000558222.1 |
